Protea Biosciences Group Inc operates within the Investment offices sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Protea Biosciences Group Inc with three other
companies in this sector in the United States:
Voya International High Dividend Equity Income Fund
sales of $1.57 million
Credit Suisse Asset Mgmnt Income Fund, I
Cohen and Steers Global Income Builder
During the year ended December of 2016, sales at
Protea Biosciences Group Inc were $2.45 million.
increase of 22.1%
versus 2015, when the company's sales were $2.00 million.
This was the fifth consecutive year of sales increases at Protea Biosciences Group Inc
(and since 2011, sales have increased a total of 243%).